Strategy advisory

Spirig Pharma AG’s  generic drugs /OTC drugs unit is the third-largest supplier of off-patent drugs in Switzerland. We performed a strategic analysis based on which the management of Spirig Pharma decided to focus on its...
[more]

Identification of targets and acquisition process: Mibelle, a subsidiary of the Migros group in its “M-Industry” segment, is a leading developer and manufacturer of private label cosmetics in Europe. In the context of the...
[more]

Development and execution of external growth strategy: Mepha is the leader for generic drugs in Switzerland with a market share of more than 35%. To secure further growth Mepha wanted to expand into new, but related fields...
[more]